SCHEMBL23508971

SCHEMBL23508971

CCC(=O)c1ncc(F)cc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 1/20 0.39
CFTR P13569 3/20 0.35
BACE1 P56817 2/20 0.35
APP P05067 1/20 0.35
BACE2 Q9Y5Z0 1/20 0.35
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12780425 0.82 AGBL2 (0.41) AGBL2BACE1MEN1CYP3A4PTGS1
SCHEMBL11978270 0.80 AGBL2 (0.39) AGBL2CFTRBACE1APPBACE2
SCHEMBL30259690 0.80 AGBL2 (0.39) AGBL2CFTRBACE1APPBACE2
SCHEMBL24852722 0.79 KDM4E (0.38) CFTRBACE1GABRA1GABRG2GABRB3
SCHEMBL17496438 0.78 SMN1; SMN2 (0.38) AGBL2BACE1APPBACE2CYP3A4
SCHEMBL14721490 0.78 HCAR2 (0.42) AGBL2BACE1APPBACE2GABRA1
SCHEMBL319381 0.76 NPSR1 (0.41) AGBL2CFTRBACE1APPBACE2
SCHEMBL18865713 0.73 APP (0.32) AGBL2BACE1APPBACE2
SCHEMBL22092246 0.70 AGBL2 (0.38) AGBL2GABRA1GABRG2GABRB3GABRA5
SCHEMBL26928475 0.69 AGBL2 (0.50) AGBL2BACE1BACE2GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021115286-A1 SIX-MEMBERED AND FIVE-MEMBERED AROMATIC RING DERIVATIVE CONTAINING NITROGEN HETEROATOMS WHICH CAN BE USED AS SHP2 INHIBITOR 成都倍特药业股份有限公司 2021-06-17 WO disclosed